Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults-Reference-Cited by-同舟云学术

Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults

Published:2021-02-03 Issue:2 Volume:4 Page:e2036321
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

McAtee Casey Lee¹,Lubega Joseph¹,Underbrink Kristen¹,Curry Kristen²,Msaouel Pavlos³,Barrow Martha¹,Muscal Eyal¹,Lotze Timothy¹,Srivaths Poyyapakkam¹,Forbes Lisa R.¹,Allen Carl¹,Bernhardt M. Brooke¹

Affiliation:

1. Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas

2. Department of Pharmacy, Texas Children’s Hospital, Houston

3. Department of Genitourinary Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2775825/mcatee_2021_oi_201086_1614014610.79044.pdf

Reference46 articles.

1. Leveraging administrative data to monitor rituximab use in 2875 patients at 42 freestanding children’s hospitals across the United States.;Kavcic;J Pediatr,2013

2. Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease.;Dale;Neurology,2014

3. Rituximab in B-cell hematologic malignancies: a review of 20 years of clinical experience.;Salles;Adv Ther,2017

4. Rituximab: mechanism of action.;Weiner;Semin Hematol,2010

5. Risk factors predisposing to the development of hypogammaglobulinemia and infections post-Rituximab.;Christou;Int Rev Immunol,2017

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B-cell Depletion Therapy in Pediatric Neuroinflammatory Disease;Current Neurology and Neuroscience Reports;2024-09-11

2. Secondary hypogammaglobulinemia: diagnosis and management of a pediatric condition of clinical importance;Current Opinion in Pediatrics;2024-09-03

3. Efficacy and safety of rituximab treatment for anti-N-methyl-D-aspartate receptor encephalitis without tumor in children;Pediatric Neurology;2024-09

4. Hospitalised infections and rituximab administration among children and adolescents with systemic lupus erythematosus from 2009 to 2021;Lupus Science & Medicine;2024-09

5. Efficacy and safety of rituximab induction therapy and effect of rituximab maintenance for IgG4-related disease: a systematic review and meta-analysis;European Journal of Internal Medicine;2024-09